Ironwood Pharmaceuticals (IRWD) announced it has engaged Goldman Sachs to explore strategic alternatives for the company to maximize value for stockholders. Ironwood Pharmaceuticals, Inc. Investor

Future Pak announced that it has submitted two formal proposals since January to acquire all outstanding common shares of Theratechnologies (THTX). The most recent offer,

Keros Therapeutics (KROS) announced that its Board has initiated a formal review process to evaluate strategic alternatives aimed at maximizing stockholder value. To oversee this

Tempest Therapeutics (TPST) announced that the company plans to explore a full range of strategic alternatives to advance its promising clinical stage programs and maximize

PureTech Health (PRTC) announced that it is in discussions with Nordic Capital Epsilon SCA, SICAV-RAIF regarding a possible cash offer to acquire the entire share

Carbon Direct Capital Management, along with certain affiliates, has submitted a non-binding proposal to acquire all outstanding shares of LanzaTech Global (LNZA) at $0.02 per

ConnectM Technology Solutions (CNTM) announced that it has received a non-binding proposal offering $1.60 per share in cash from its three largest institutional investors—SriSid, Arumilli,

Reuters reported that WNS Holdings (WNS), a technology outsourcing services firm with a market value of $2.8 billion, is exploring a sale after attracting acquisition

U.S. contract chipmaker GlobalFoundries (GFS) and United Microelectronics (UMC), Taiwan’s second largest chipmaker, are exploring the possibility of a merger amid American efforts to mitigate

VivoPower International (VVPR) has announced that it has received an unsolicited, non-binding takeover proposal from Abu Dhabi-based Energi Holdings Limited. The proposal is an all-cash

Wag! Group (PET) announced that its Board of Directors is advancing its review of strategic alternatives aimed at maximizing shareholder value. The options under consideration

Bloomberg reported that TOMS Capital Investment Management has amassed a stake in Kenvue (KVUE) and is pushing for changes at the consumer health company. The